Text Size

Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions

This study has suspended participant recruitment.
(Study was not renewed timely with IRB of record.)
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier:
NCT00250757
First received: November 4, 2005
Last updated: February 18, 2013
Last verified: February 2013
History of Changes
  Purpose

To develop the hypothesis that quantitative NMR spectroscopy of human semen can be used to diagnose prostate cancer.


Condition
Prostate Cancer

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by New Mexico Cancer Care Alliance:

Biospecimen Retention:   Samples Without DNA

Semen samples or Prostatic secretions (via prostate massage).


Estimated Enrollment: 40
Study Start Date: October 2005
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Detailed Description:

Any willing subject who meets the male gender requirements, who is competent, agrees to participate, and is able to understand the consent form.

  Eligibility

Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Males with and without Prostate cancer.

Criteria

Inclusion Criteria:

  • Any willing subject who meets the male gender requirements, who is competent, agrees to participate, and is able to understand the consent form.

Exclusion Criteria:

  • Not sepcified.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00250757

Locations
United States, New Mexico
University of New Mexico Cancer Center
Albuquerque, New Mexico, United States, 87106
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Laurel Sillerud, MD University of New Mexico
  More Information

No publications provided

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00250757     History of Changes
Other Study ID Numbers: 2904C
Study First Received: November 4, 2005
Last Updated: February 18, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by New Mexico Cancer Care Alliance:
prostate
NMR Spectroscopy

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
 Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on May 23, 2013